Cho et al., showed that in FIGO stage I endometrial cancer, osteopontin correctly identified the majority of cases (62.1%) and pinpointed osteopontin as an independent prognostic factor for disease-free survival [88]. The gene discussed is SPP1; the disease is endometrial cancer.